IBC’s Advances in Structure-Guided Drug Discovery conference answers this question: Do structure-guided drug discovery strategies yield compounds that make it into clinical trials? The conference program offers a comprehensive overview of the latest innovations and applications of structure-guided strategies to speed the discovery of novel drug candidates. The meeting delivers critical information on protein modeling tools, in silico, ligand-target simulation methods for library selection and virtual high through put screening.